Smarter Biomanufacturing, Validated by Science.
From Bioreactor to Algorithm
We combine wet-lab process development and machine learning to help biotech teams build scalable, predictable manufacturing systems.




Our Services
Build & validate SOPs
The AI + human hybrid model revolutionizes how Standard Operating Procedures (SOPs) are built and validated by combining the precision of artificial intelligence with the domain expertise of scientists and engineers. AI tools quickly draft SOPs by analyzing large datasets and best practices, while human experts refine the content for context, compliance, and usability. This synergy speeds up documentation, ensures regulatory alignment, and promotes smoother adoption on the lab floor.

Clean & digitize your batch data

Batch data, often messy and trapped in paper forms or fragmented spreadsheets, becomes a rich asset through AI-assisted digitization. The hybrid model uses machine learning algorithms to identify inconsistencies, fill gaps, and structure the data, while humans provide context, troubleshoot errors, and validate final outputs. This results in clean, queryable datasets that unlock deeper insights and improve traceability, audit readiness, and operational efficiency.
Create predictive models to optimize performance
Once data is clean and structured, the AI + human team co-develops predictive models to anticipate outcomes and suggest optimizations. AI identifies patterns across process variables, while human experts ensure that predictions are biologically and operationally meaningful. These models help proactively adjust conditions, reduce variability, and maximize yield, enabling smarter, faster decision-making throughout the production lifecycle.

CMC Consultation & Strategy
Our CMC Consultation & Strategy service integrates advanced AI to accelerate and optimize every stage of drug development. Leveraging predictive analytics and machine learning, we perform early-stage feasibility and manufacturability assessments with enhanced precision—identifying scale-up challenges before they arise. AI-powered tools streamline the creation of IND-enabling CMC packages, ensuring regulatory compliance with greater speed and accuracy. Through intelligent regulatory roadmap planning and dynamic risk modeling, we help clients foresee potential hurdles and proactively navigate them. With AI at the core, we transform complex data into clear, actionable strategy—bringing therapies to patients faster and more efficiently.
